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P reoperative diagnostic methods have not been established to distinguish follicular thyroid carci-
noma (FTC) from follicular thyroid adenoma (FTA) [1].  
Although ultrasonography (US)-guided fine needle 
aspiration (FNA) cytology of thyroid nodules has 
become the dominant modality for assessing the need 
for a resection of thyroid nodules,  among 219 patients 
with preoperative FNAs reported as “suspicious for fol-
licular neoplasm,” only 19 (8.7%) were actually FTCs 
[2].  The rate of invasive FTCs among all follicular neo-
plasms is only 2% [3].  However,  since the malignant 
potential of follicular neoplasms can rarely be deter-
mined from a cytological evaluation alone,  many 
patients are advised to undergo surgical resection [4].  
We conducted the present study to determine specific 
CT features for distinguishing FTCs from FTAs.
Patients and Methods
Study population. This study included 205 
patients who underwent preoperative neck CT and sur-
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Since no diagnostic method has been established to distinguish follicular thyroid carcinoma (FTC) from follic-
ular thyroid adenoma (FTA),  surgery has been the only way to reach a diagnosis of follicular neoplasm.  Here 
we investigated the computed tomography (CT) features of follicular neoplasms,  toward the goal of being able 
to identify specific CT features allowing the preoperative differentiation of FTC from FTA.  We retrospectively 
analyzed the cases of 205 patients who underwent preoperative CT of the neck and were histopathologically 
diagnosed with FTC (n = 31) or FTA (n = 174) after surgery between January 2002 and June 2016 at several hos-
pitals in Japan.  In each of these 205 cases,  non-enhanced and contrast-enhanced CT images were obtained,  and 
we analyzed the CT features.  On univariate analysis,  inhomogeneous features of tumor lesions on contrast-en-
hanced CT were more frequently observed in FTC than in FTA (p= 0.0032).  A multivariate analysis identified 
inhomogeneous features of tumor lesions on contrast-enhanced CT images as an independent variable indica-
tive of FTC (p= 0.0023).  CT thus offers diagnostic assistance in distinguishing FTC from FTA.
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gery and were histopathologically diagnosed with FTC 
(n = 31) or FTA (n = 174) at Okayama University 
Hospital,  Himeji Red-Cross Hospital,  or National 
Hospital Organization Okayama Medical Center 
between January 2002 and June 2016.  We identified 
these 205 cases by reviewing the medical and patholog-
ical records.  All study protocols were approved by the 
institutional review board at each of the hospitals.  The 
choice to perform surgery was at the discretion of the 
attending physician.  Our fundamental policy for the 
treatment of thyroid nodules is to do our best to avoid 
unnecessary surgery,  by considering the results of 
US-guided FNA cytology,  clinical symptoms,  patient 
age,  tumor size,  imaging studies,  laboratory findings,  
or patient requests.
Neck CT. Both non-enhanced and contrast-en-
hanced CT images were obtained from each of the 205 
patients.  CT examinations were performed with CT 
scanners (Aquilion 64 or Aquilion One; Toshiba Medical 
System Corp.,  Tokyo).  The acquisition parameters 
were: 120 kV; Auto Exposure Control (SD10); rota-
tion time,  0.5 sec; pitch,  0.844 or 0.637; field of view,  
24 cm; matrix size,  512 × 512 pixels; detector collima-
tion,  32 mm×1.0 mm; slice thickness,  1 mm or 5 mm;  
and slice increment,  1 mm or 5 mm.  Contrast-
enhanced images were obtained after an intravenous 
injection of contrast medium (300 mg of non-ionized 
iodine per mL,  2 ml/kg) at 1 mL/sec,  starting 60 sec 
after the initiation of contrast media.
We have noted the following 3 patterns on CT 
images of follicular neoplasms.  Type 1: The tumor 
lesion is depicted as an inhomogeneous feature on con-
trast-enhanced images,  but depicted as homogeneous 
on non-enhanced images (Fig. 1A).  Type 2: The tumor 
lesion is depicted as a homogeneous feature on both 
non-contrast and contrast-enhanced images (Fig. 1B).  
Type 3: The tumor lesion is depicted as an inhomoge-
neous feature on non-contrast images and depicted as 
the same inhomogeneous feature on contrast-enhanced 
images (Fig. 1C).
We defined type 1 as an inhomogeneous enhanced 
pattern depicted on only contrast-enhanced images,  
and types 2 and 3 as a homogeneous enhanced pattern.  
In other words,  we hypothesized that an irregular 
enhancement of nodules regardless of non-contrast CT 
values may suggest a malignant lesion.  The type on CT 
images was decided by three investigators (T. Makino,  
Y. Orita,  and T. Tachibana) who were blinded to the 
histopathological findings of the cases.  In cases of dis-
crepancies,  a consensus was reached by discussion 
among these three investigators.
Statistical analysis. Uni- and multivariate logis-
tic regression analyses were used to evaluate the predic-
tive power of several variables to distinguish FTCs from 
FTAs.  All analyses were performed using SPSS ver. 
21.0J software (SPSS,  Armonk,  NY,  USA).  Values of 
p < 0.05 were accepted as significant,  and values of 
p < 0.1 were considered to indicate a tendency.
Results
The mean age of the 205 patients (FTC,  n = 31;  
FTA,  n= 174) was 58 years (range 15-83 years).  Forty-
six (22%) were male and 159 (78%) were female.  The 
mean major axis of thyroid nodules was 32 mm (range 
10-77 mm).  A mean value could not be calculated for 
the patients’ serum thyroglobulin levels,  because the 
values at one of the 3 hospitals were recorded as 
≥ 500 ng/ml when the values were > 500 ng/ml.
An inhomogeneous pattern depicted on contrast- 
enhanced CT was observed in 100 patients (49%).  
According to our definition for the CT images to dis-
criminate between FTC and FTA,  the sensitivity was 
74.2%,  the specificity was 55.7%,  and the accuracy was 
58.5%.  US-guided FNA cytology was conducted in 143 
FTA cases and 22 FTC cases.  Among the FTA patients,  
1 case was Class I,  88 cases were Class II,  52 cases were 
Class III,  and 2 cases were Class IV.  Among the FTC 
patients,  12 cases were Class II,  and 10 cases were 
Class III.  When we hypothesized that Class III and Class 
IV were “suspicious of malignant tumors,” the sensitiv-
ity was 45.5%,  the specificity was 62.2%,  and the accu-
racy was 60.0%.  In addition,  the sensitivity,  specificity 
and accuracy using the CT images and US-guided FNA 
cytology were 31.8%,  83.9% and 88.8%,  respectively.
The mean duration of follow-up for the patients with 
FTC or FTA after their first presentation to the hospital 
was 12 months (range 0-154 months).  Among the 31 
FTC cases,  5 showed distant metastasis (synchronous,  
n = 4; metachronous,  n = 1) during the observational 
period.  Each of these 5 cases showed an inhomoge-
neous pattern on contrast-enhanced CT.  After classify-
ing findings from CT,  only a few cases need to be dis-
cussed.
The results of the univariate analysis for these vari-
ables are shown in Table 1.  Inhomogeneous tumor 
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Table 1 Univariate analysis of characteristics of the 205 patients with FTC or FTA
Characteristics FTC (n＝31) FTA (n＝174) p-value
Age＃ ≥45 years (mean,  58; range,  15-83) 26 (84%) 118 (68%) 0.086
Sex,  male 11 (35%) 35 (20%) 0.11
Major axis＊ ≥40 mm (mean,  32; range,  10-77) 14 (45%) 54 (31%) 0.19
Tg ≥300 ng/mL 11 (35%) 55 (32%) 0.57
Inhomogeneous enhanced CT pattern 23 (74%) 77 (44%) 0.0032
FTC,  follicular thyroid carcinoma; FTA,  follicular thyroid adenoma; Tg,  serum thyroglobulin.
＃Age,  age at initial thyroid operation.
＊Major axis,  major axis of thyroid nodules.
Fig. 1 A,  Type 1,  the tumor lesion is depicted 
as an inhomogeneous feature on contrast-en-
hanced images,  but depicted as homogeneous 
on non-enhanced images; B,  Type 2,  the tumor 
lesion is depicted as a homogeneous feature on 
both non-contrast and contrast-enhanced imag-
es; C,  Type 3,  the tumor lesion is depicted as 
an inhomogeneous feature both on non-contrast 
and contrast-enhanced images.
lesions on contrast-enhanced CT were more frequently 
observed in the FTC cases than in the FTA cases 
(p = 0.0032).  FTC tended to be more prevalent among 
older patients (≥ 45 years) than among younger patients 
(< 45 years; p = 0.086).  The multivariate analyses to 
evaluate the simultaneous effects of variables for distin-
guishing FTCs from FTAs (Table 2) revealed inhomoge-
neous features of the tumor lesion on contrast-en-
hanced CT as an independent characteristic to indicate 
FTC (p = 0.0030).
Discussion
CT often aids in the preoperative assessment of the 
location and extent of intrathoracic tissue and its rela-
tionship to the major vascular structures,  and is used as 
a major radiological staging method when evaluating 
the extent of cervical and mediastinal adenopathy in 
patients with thyroid carcinoma prior to radical surgery 
[5].  Ultrasonography provides greater spatial resolution 
than CT and affords an improved evaluation of nodule 
architecture and consistency [6],  and we usually first 
evaluate thyroid nodules by US.  Although we almost 
routinely perform preoperative CT,  the usefulness of 
CT for the diagnosis of thyroid tumor has not been 
investigated,  and only a few attempts have been made to 
distinguish malignant thyroid nodules from benign 
nodules on CT [5-7].
Kim et al.  [7] reported that an exophytic configura-
tion,  irregular margin,  taller-than-wide shape,  punc-
tate calcifications,  and homogeneously decreased 
enhancement were associated with a high malignancy 
rate.  The same group [8] reported that an expansile 
configuration (i.e.,  a blunt angle between the lesion and 
the adjacent thyroid capsule),  increased enhancement,  
and the presence of the CT halo sign were more fre-
quently observed in follicular neoplasms than in nodu-
lar hyperplasia.  In the present study,  the accuracy 
using the CT images was 58.5%.  Jung et al.  [9] reported 
that the sensitivity,  specificity and accuracy of US fea-
tures for follicular tumors of thyroid were 50.6%,  
89.5% and 76.2%,  respectively.  It is clear that US is 
superior to CT in the diagnosis of follicular tumors,  but 
our present analyses revealed that the inhomogeneous 
pattern of thyroid nodules depicted on contrast-en-
hanced CT offers a simple and effective method to sug-
gest FTC,  which every physician in every hospital,  
even non-radiologists,  can easily detect.  Our findings 
also suggest that the diagnosis of follicular neoplasm 
may become more accurate by combining the use of CT 
images and US-guided FNA cytology.
The incidence rate of FTC is higher among females 
than among males [9],  and 20 of the 31 FTC patients 
(65%) in the present study were females.  The gender 
incidence rate for FTC did not differ significantly from 
that for FTA.  Some studies have shown that large size of 
a thyroid tumor is predictive of malignancy [10 , 11];  
however,  we did not observe any significant difference 
in tumor size between the FTCs and FTAs.  This dis-
crepancy may be due to the fact that the patients with a 
major tumor axis < 10 mm did not undergo surgery and 
thus were not included in the present study.
The preoperative serum Tg concentration was 
reported to be higher in follicular and Hürthle cell can-
cers than in benign neoplasms [12].  In the present 
patient series,  there was no significant difference in 
serum Tg concentration between the FTC and FTA 
groups.
Several limitations must be considered when inter-
preting our results.  First,  US-guided FNA shows a rel-
atively high false-positive rate (35%) for the preopera-
tive detection of follicular neoplasm [13],  and nodular 
hyperplasia cases that had been preoperatively “misdi-
agnosed” as follicular neoplasm when the decision 
regarding whether surgery would be performed were 
not included in this study.  Prospective investigations 
are necessary to confirm the validity of the present find-
ings.  Second,  the distinction between FTC and FTA is 
based on the histological demonstration of capsular or 
vascular invasion,  but even these histological findings 
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Table 2 Multivariate analysis of characteristics for distinguishing FTCs from FTAs
Characteristics Risk ratio 95%CI p-value
Age＃,  ≥45 years (mean,  58; range,  15-83) 2.58 0.93-7.20 0.0701
Inhomogeneous enhanced CT pattern 3.71 1.56-8.82 0.0030
FTC,  follicular thyroid carcinoma; FTA,  follicular thyroid adenoma.
＃Age,  age at initial thyroid operation.
are convenient diagnostic criteria for which the reliabil-
ity may not be 100%.  In the present study,  5 of the 31 
FTC cases showed distant metastasis during the obser-
vational period.  An accumulation of more “true” FTC 
cases that show distant metastasis is needed.  Third,  
adapting this characteristic CT finding for the diagnosis 
of < 10-mm thyroid nodules (for which we usually do 
not perform surgery) will be difficult.
In conclusion,  computed tomography offers diag-
nostic assistance in distinguishing follicular thyroid 
carcinoma from follicular thyroid adenoma.  Routinely 
performed CT images should be more efficiently used 
by combining CT with the use of US or FNA cytology.
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